I agree that this site is using cookies. You can find further informations here.
X
Cather, Jennifer
60  results:
Search for persons X
?
1

357 The effect of upadacitinib on the genital region in mod..:

Cather, Jennifer ; Magnolo, Nina ; Cameron, Michael...
British Journal of Dermatology.  188 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
2

Deucravacitinib, an oral, selective, allosteric tyrosine ki..:

Bagel, Jerry ; Armstrong, April W. ; Warren, Richard B....
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s117 , 2023
Link: https://doi.org/10.25251..
 
?
3

Tapinarof Cream 1% Once Daily: Disease Control Off Treatmen..:

Strober, Bruce ; Zeichner, Joshua A. ; Desai, Seemal R....
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s125 , 2023
Link: https://doi.org/10.25251..
 
?
4

A Review of Phase 3 Trials of Dupilumab for the Treatment o..:

Cather, Jennifer ; Young, Melodie ; DiRuggiero, Douglas C....
Dermatology and Therapy.  12 (2022)  9 - p. 2013-2038 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Deucravacitinib, an oral, selective tyrosine kinase 2 inhib..:

Bagel, Jerry ; Armstrong, April ; Warren, Richard...
SKIN The Journal of Cutaneous Medicine.  6 (2022)  6 - p. s47 , 2022
Link: https://doi.org/10.25251..
 
?
6

33817 Bimekizumab efficacy and safety in patients with mode..:

Lebwohl, Mark ; Ghoreschi, Kamran ; Strober, Bruce...
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB145 , 2022
Link: https://doi.org/10.1016/..
 
?
7

25357 Malignancies related to study drug and leading to dis..:

Friedman, Adam ; Vender, Ronald B. ; Desai, Mital...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB56 , 2021
Link: https://doi.org/10.1016/..
 
?
8

26691 Rapid and concurrent improvements in the signs and sy..:

Lio, Peter ; Soung, Jennifer ; Cather, Jennifer...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB113 , 2021
Link: https://doi.org/10.1016/..
 
?
9

14161 Ixekizumab is superior to placebo for the treatment o..:

Paller, Amy S. ; Alejandro Magariños, Gabriel ; Pinter, Andreas...
Journal of the American Academy of Dermatology.  83 (2020)  6 - p. AB20 , 2020
Link: https://doi.org/10.1016/..
 
?
10

15966 Rates of malignancies through 5 years of tildrakizuma..:

Cather, Jennifer ; Nardone, Beatrice ; Parno, Jeff...
Journal of the American Academy of Dermatology.  83 (2020)  6 - p. AB165 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Long‐term efficacy and safety of topical glycopyrronium tos..:

Hebert, Adelaide A. ; Glaser, Dee Anna ; Green, Lawrence...
Pediatric Dermatology.  37 (2020)  3 - p. 490-497 , 2020
Link: https://doi.org/10.1111/..
 
?
12

A series of critically challenging case scenarios in modera..:

Strober, Bruce ; Berger, Emily ; Cather, Jennifer...
Journal of the American Academy of Dermatology.  61 (2009)  1 - p. S1-S46 , 2009
Link: https://doi.org/10.1016/..
 
?
13

Alefacept revisited: Our 3-year clinical experience in 200 ..:

Perlmutter, Amy ; Cather, Jennifer ; Franks, Billy..
Journal of the American Academy of Dermatology.  58 (2008)  1 - p. 116-124 , 2008
Link: https://doi.org/10.1016/..
 
?
14

Atypical CD8+ Cutaneous T-Cell Lymphoma After Immunomodulat..:

Berthelot, Cindy ; Cather, Jennifer ; Jones, Dan.
Clinical Lymphoma and Myeloma.  6 (2006)  4 - p. 329-332 , 2006
Link: https://doi.org/10.3816/..
 
?
15

Efalizumab: A Viewpoint by Jennifer Cather:

Cather, Jennifer
American Journal of Clinical Dermatology.  6 (2005)  2 - p. 119-120 , 2005
Link: https://doi.org/10.2165/..
 
1-15